SUWON, Republic of Korea, Jan. 06, 2021 (GLOBE NEWSWIRE) -- OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced that the Company’s management will present at the 2021 ICR Conference, being held virtually January 11-14, 2021.

Read more here:
OliX Pharmaceuticals to Present at 2021 ICR Conference

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh